Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  17 results for ""GOW, Andrew""

Your Filters

Subject : thymic stromal lymphopoietin
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Efficacy of tezepelumab in patients with evidence of severe allergic asthma: Results from the phase 3 NAVIGATOR study.

Subjects: EUROPEAN Union; ASTHMA; ASTHMATICS

  • Source: Clinical & Experimental Allergy. Apr2023, Vol. 53 Issue 4, p417-428. 12p. 3 Charts, 4 Graphs.

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR.

Subjects: NASAL polyps; VOCAL cord dysfunction; THYMIC stromal lymphopoietin

  • Source: Journal of Asthma & Allergy; Sep2023, Vol. 16, p915-932, 18p

Record details

Read More Add to Saved list
×
Academic Journal

Efficacy of Tezepelumab in Severe, Uncontrolled Asthma: Pooled Analysis of the PATHWAY and NAVIGATOR Clinical Trials.

Subjects: ASTHMA; CLINICAL trials; EXPLORERS

  • Source: American Journal of Respiratory & Critical Care Medicine; 7/1/2023, Vol. 208 Issue 1, p13-24, 12p

Record details

Read More Add to Saved list
×
Academic Journal

Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.

Subjects: THYMIC stromal lymphopoietin; ASTHMA; PATIENT complianceASTRAZENECA PLC; AMGEN Inc.

  • Source: Lancet Respiratory Medicine; May2023, Vol. 11 Issue 5, p425-438, 14p

Record details

Read More Add to Saved list
×
Academic Journal

Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.

Subjects: THYMIC stromal lymphopoietin; ASTHMA; MONOCLONAL antibodiesAMGEN Inc.

  • Source: Lancet Respiratory Medicine; Jul2022, Vol. 10 Issue 7, p650-660, 11p

Record details

Read More Add to Saved list
×
Academic Journal

Targeting TSLP in Asthma.

Subjects: THYMIC stromal lymphopoietin; ASTHMA; ASTHMATICS

  • Source: Journal of Asthma & Allergy; Jun2022, Vol. 15, p749-765, 17p

Record details

Read More Add to Saved list
×
Academic Journal

Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial.

Subjects: AIRWAY (Anatomy); ASTHMA; THYMIC stromal lymphopoietin

  • Source: Lancet Respiratory Medicine; Nov2021, Vol. 9 Issue 11, p1299-1312, 14p

Record details

Read More Add to Saved list
×
Academic Journal

NAVIGATOR: a phase 3 multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the efficacy and safety of tezepelumab in adults and adolescents with severe, uncontrolled asthma.

Subjects: THYMIC stromal lymphopoietin; ASTHMA; CLUSTER randomized controlled trials

  • Source: Respiratory Research; 10/13/2020, Vol. 21 Issue 1, p1-12, 12p

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Efficacy and safety of tezepelumab in patients recruited in Japan who participated in the phase 3 NAVIGATOR study.

Subjects: *THYMIC stromal lymphopoietin; *PATIENT safety; *FORCED expiratory volumeJAPAN

  • Source: Allergology International. Jan2023, Vol. 72 Issue 1, p82-88. 7p.

Record details

Read More Add to Saved list
×
Academic Journal

DESTINATION: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel-group trial to evaluate the long-term safety and tolerability of tezepelumab in adults and adolescents with severe, uncontrolled asthma.

Subjects: *THYMIC stromal lymphopoietin; *CLUSTER randomized controlled trials; *ASTHMA

  • Source: Respiratory Research. 10/21/2020, Vol. 21 Issue 1, pN.PAG-N.PAG. 1p.

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  17 results for ""GOW, Andrew""